Retinoids control the expression of c-erbB receptors in breast cancer cells

被引:27
作者
Offterdinger, M [1 ]
Schneider, SM [1 ]
Huber, H [1 ]
Grunt, TW [1 ]
机构
[1] Univ Vienna, Dept Internal Med 1, Div Oncol, Lab Cell Growth & Differentiat, A-1090 Vienna, Austria
关键词
retinoids; c-erbB; receptor; expression; breast cancer;
D O I
10.1006/bbrc.1998.9570
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear retinoid and membrane c-erbB receptors participate in signal transduction systems that control mammary epithelial cell proliferation and differentiation. Recently, we demonstrated that c-erbB receptor activation stimulates retinoic acid receptor-a expression. We now report that retinoids reduce SKBR-3 breast cancer cell growth by inhibiting the cell cycle and by inducing apoptosis. This is accompanied with reduced c-erbB expression as determined by FAGS, Western, Northern, RT-PCR, and reporter assays. All-trans (ATRA) and g-cis retinoic acid (9cRA) reduce c-erbB-1 protein to 50-100%, c-erbB-2 to 20-30%, and c-erbB-3 to 10-50% of control, depending on the concentration, respectively, without influencing the tyrosine phosphorylation status. Down-regulation of c-erbB-2 and -3 was seen at all levels analyzed, whereas c-erbB-1 mRNA remained unchanged. Retinoic acid-mediated down-regulation of growth and c-erbB-2 and -3 expression was also seen in MCF-7 cells. We conclude that retinoic acids are efficient repressors of c-erbB-2 and -3 gene expression, whereas c-erbB-1 is not markedly affected. (C) 1998 Academic Press.
引用
收藏
页码:907 / 913
页数:7
相关论文
共 41 条
[1]   Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors [J].
Alimandi, M ;
Wang, LM ;
Bottaro, D ;
Lee, CC ;
Kuo, A ;
Frankel, M ;
Fedi, P ;
Tang, C ;
Lippman, M ;
Pierce, JH .
EMBO JOURNAL, 1997, 16 (18) :5608-5617
[2]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[3]   DIFFERENTIATION OF CULTURED HUMAN BREAST-CANCER CELLS (AU-565 AND MCF-7) ASSOCIATED WITH LOSS OF CELL-SURFACE HER-2/NEU ANTIGEN [J].
BACUS, SS ;
KIGUCHI, K ;
CHIN, D ;
KING, CR ;
HUBERMAN, E .
MOLECULAR CARCINOGENESIS, 1990, 3 (06) :350-362
[4]  
BACUS SS, 1992, CANCER RES, V52, P2580
[5]   THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
NATURE, 1986, 319 (6050) :226-230
[6]   An intron 1 enhancer element mediates oestrogen-induced suppression of ERBB2 expression [J].
Bates, NP ;
Hurst, HC .
ONCOGENE, 1997, 15 (04) :473-481
[7]   A decade of molecular biology of retinoic acid receptors [J].
Chambon, P .
FASEB JOURNAL, 1996, 10 (09) :940-954
[8]   RAR-SPECIFIC AGONIST/ANTAGONISTS WHICH DISSOCIATE TRANSACTIVATION AND AP1 TRANSREPRESSION INHIBIT ANCHORAGE-INDEPENDENT CELL-PROLIFERATION [J].
CHEN, JY ;
PENCO, S ;
OSTROWSKI, J ;
BALAGUER, P ;
PONS, M ;
STARRETT, JE ;
RECZEK, P ;
CHAMBON, P ;
GRONEMEYER, H .
EMBO JOURNAL, 1995, 14 (06) :1187-1197
[9]   Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-alpha in SK-BR-3 breast cancer cells [J].
Flicker, SH ;
Schneider, SM ;
Offterdinger, M ;
Dittrich, E ;
Fazeny, B ;
Valenta, R ;
Huber, H ;
Dittrich, C ;
Grunt, TW .
CANCER LETTERS, 1997, 115 (01) :63-72
[10]  
FONTANA JA, 1992, CANCER RES, V52, P3938